risks of glp 1 drugs GLP-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study Nutritional Side Effects of GLP-1

As we stated in the CY 2026 PFS proposed rule (90 FR 32678), we believe that the eCQM/MIPS CQM reporting incentive and the Complex Organization Adjustment sufficiently support ACOs to address the unique challenges they face when reporting all payer/all patient measures and sufficiently support ACOs that serve large proportions of beneficiaries dually eligible for Medicare and Medicaid and the Medicare Part D LIS

In our practice, constipation is one of the most consistently reported problems on GLP-1 therapy, particularly in the first weeks of a new dose

Nature 594 , 259264 (2021)

The pre-dissolved liquid is absorbed directly through the mucosal lining achieving 35x higher plasma levels than the equivalent capsule dose

Nutr Metab Cardiovasc Dis 2022;32:2279-2288

Joshua Goldenberg: So, yeah